These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 9413748)

  • 21. Natural killing of xenogeneic cells mediated by the mouse Ly-49D receptor.
    Nakamura MC; Naper C; Niemi EC; Spusta SC; Rolstad B; Butcher GW; Seaman WE; Ryan JC
    J Immunol; 1999 Nov; 163(9):4694-700. PubMed ID: 10528166
    [TBL] [Abstract][Full Text] [Related]  

  • 22. H-2Dp transgene alters natural killer cell specificity at the target and effector cell levels. Comparison with an H-2Dd transgene.
    Sentman CL; Olsson-Alheim MY; Lendahl U; Kärre K
    J Immunol; 1996 Apr; 156(7):2423-9. PubMed ID: 8786300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NK-mediated elimination of mutant lymphocytes that have lost expression of MHC class I molecules.
    Kusunoki Y; Kyoizumi S; Honma M; Kubo Y; Ohnishi H; Hayashi T; Seyama T
    J Immunol; 2000 Oct; 165(7):3555-63. PubMed ID: 11034355
    [TBL] [Abstract][Full Text] [Related]  

  • 24. YAC-1 MHC class I variants reveal an association between decreased NK sensitivity and increased H-2 expression after interferon treatment or in vivo passage.
    Piontek GE; Taniguchi K; Ljunggren HG; Grönberg A; Kiessling R; Klein G; Kärre K
    J Immunol; 1985 Dec; 135(6):4281-8. PubMed ID: 3905967
    [TBL] [Abstract][Full Text] [Related]  

  • 25. NK cell response to viral infections in beta 2-microglobulin-deficient mice.
    Tay CH; Welsh RM; Brutkiewicz RR
    J Immunol; 1995 Jan; 154(2):780-9. PubMed ID: 7529286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive recognition of MHC class I molecules by the Ly49D receptor of murine NK cells.
    George TC; Mason LH; Ortaldo JR; Kumar V; Bennett M
    J Immunol; 1999 Feb; 162(4):2035-43. PubMed ID: 9973475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Reconstitution of H-2 class I expression by gene transfection decreases susceptibility to natural killer cells of an EL4 class I loss variant.
    Sturmhöfel K; Hämmerling GJ
    Eur J Immunol; 1990 Jan; 20(1):171-7. PubMed ID: 2106441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Window of vulnerability of vaccinia virus-infected cells to natural killer (NK) cell-mediated cytolysis correlates with enhanced NK cell triggering and is concomitant with a decrease in H-2 class I antigen expression.
    Brutkiewicz RR; Klaus SJ; Welsh RM
    Nat Immun; 1992; 11(4):203-14. PubMed ID: 1421956
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The MHC class I molecule H-2Dp inhibits murine NK cells via the inhibitory receptor Ly49A.
    Olsson-Alheim MY; Sundbäck J; Kärre K; Sentman CL
    J Immunol; 1999 Jun; 162(12):7010-4. PubMed ID: 10358142
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NK 1+ CD4- CD8- alphabeta T cells in the peritoneal cavity: specific T cell receptor-mediated cytotoxicity and selective IFN-gamma production against B cell leukemia and myeloma cells.
    Sugie T; Kubota H; Sato M; Nakamura E; Imamura M; Minato N
    J Immunol; 1996 Nov; 157(9):3925-35. PubMed ID: 8892624
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Stimulation of murine natural killer (NK) cells by a monoclonal antibody specific for the NK1.1 antigen. IL-2-activated NK cells possess additional specific stimulation pathways.
    Karlhofer FM; Yokoyama WM
    J Immunol; 1991 May; 146(10):3662-73. PubMed ID: 2026886
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Splenocytes cultured in low concentrations of IL-2 generate NK cell specificities toward syngenic and allogenic targets.
    Nissen MH; Jeppesen M; Claesson MH
    Cell Immunol; 2000 Jul; 203(1):47-54. PubMed ID: 10915561
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abrogation of graft-vs.-leukemia activity after depletion of CD3+ T cells in a murine model of MHC-matched peripheral blood progenitor cell transplantation (PBPCT).
    Uharek L; Glass B; Zeis M; Dreger P; Steinmann J; Löffler H; Schmitz N
    Exp Hematol; 1998 Feb; 26(2):93-9. PubMed ID: 9472798
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Lymphocyte-mediated cytotoxicity against allogeneic tumour cells. IV. Fine specificity mapping and characterization of concanavalin A-activated cytotoxic effector lymphocytes.
    Waterfield JD; Nixon DF; Mair MG
    Immunology; 1981 Dec; 44(4):685-93. PubMed ID: 6797935
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tolerance and alloreactivity of the Ly49D subset of murine NK cells.
    George TC; Ortaldo JR; Lemieux S; Kumar V; Bennett M
    J Immunol; 1999 Aug; 163(4):1859-67. PubMed ID: 10438920
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Target cell expression of MHC antigens is not (always) a turn-off signal to natural killer cells.
    Chervenak R; Wolcott RM
    J Immunol; 1988 Jun; 140(11):3712-6. PubMed ID: 3259596
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Activated allogeneic NK cells as suppressors of alloreactive responses.
    Hu B; He Y; Wu Y; Bao G; Liu H; Welniak LA; Murphy WJ
    Biol Blood Marrow Transplant; 2010 Jun; 16(6):772-81. PubMed ID: 20197103
    [TBL] [Abstract][Full Text] [Related]  

  • 38. MHC class I expression on tumor targets inhibits natural killer cell-mediated cytotoxicity without interfering with target recognition.
    Kaufman DS; Schoon RA; Leibson PJ
    J Immunol; 1993 Feb; 150(4):1429-36. PubMed ID: 8432986
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MHC class I mosaic mice reveal insights into control of Ly49C inhibitory receptor expression in NK cells.
    Andersson M; Freland S; Johansson MH; Wallin R; Sandberg JK; Chambers BJ; Christensson B; Lendahl U; Lemieux S; Salcedo M; Ljunggren HG
    J Immunol; 1998 Dec; 161(12):6475-9. PubMed ID: 9862670
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Heterogeneity of lymphokine-activated killer cells induced by IL-2. Separate lymphoid subpopulations lyse tumor, allogeneic blasts, and modified syngeneic blasts.
    LeFor AT; Eisenthal A; Rosenberg SA
    J Immunol; 1988 Jun; 140(11):4062-9. PubMed ID: 3259603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.